semaglutide gut microbiome Frontiers Ozempic and the Gut Microbiome:

Abubakar M, Nama L, Ansari MA, Ansari MM, Bhardwaj S, Daksh R, Syamala KLV, Jamadade MS, Chhabra V, Kumar D, Kumar N (2024) GLP-1/GIP Agonist as an Intriguing and Ultimate Remedy for Combating Alzheimers Disease through its Supporting DPP4 Inhibitors: A Review

Effective weight management is crucial for reducing the risk of these health complications

As a result, drugs such as semaglutide and liraglutide became valuable tools not only for glycemic management but also for cardiovascular risk reduction

The market's growth is further supported by the approval of new indications, innovative product launches such as oral GLP-1 formulations, and wider integration of these drugs into home care and fitness settings

The concern has gained attention as use of these medications has expanded dramatically

USA 97 , 787792 (2000)